IP Library › Assignment 046202/0822
Patent Assignment
Reel/Frame 046202/0822

Assignment of Assignor's Interest

Recorded: 2018-06-26 Pages: 5
Assignors
ZHANG, XIAOKUI
Executed: 2010-09-08
VOSKINARIAN-BERSE, VANESSA
Executed: 2010-08-19
KANG, LIN
Executed: 2010-08-19
PADLIYA, NEERAV DILIP
Executed: 2010-08-18
PAL, AJAI
Executed: 2010-08-18
ZEITLIN, ANDREW
Executed: 2010-08-19
Assignee
ANTHROGENESIS CORPORATION
7 POWDER HORN DRIVE, WARREN, NEW JERSEY, 07059
Covered Properties (4)
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
Patent: 9,216,200 →
Application: 13/584,612 →
Publication: US 2014/0093488
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
Application: 14/942,337 →
Publication: US 2016/0287635
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
Application: 60/995,763 →
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
Application: 61/090,555 →
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 24, 2009
From: HEIDARAN, MOHAMMAD A.; KANG, LIN; PAL, AJAI; ZEITLIN, ANDREW
To: ANTHROGENESIS CORPORATION
Reel/Frame 022301/0361 →
Assignment of Assignor's Interest Jun 29, 2010
From: ZHANG, XIAOKUI; PADLIYA, NEERAV D.; VOSKINARIAN-BERSE, VANESSA R.; KANG, LIN
To: ANTHROGENESIS CORPORATION
Reel/Frame 024612/0934 →
Merger Nov 8, 2017
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 044413/0680 →
Assignment of Assignor's Interest Nov 9, 2017
From: CLARITY ACQUISITION II LLC
To: CELULARITY, INC.
Reel/Frame 044780/0261 →
Assignment of Assignor's Interest Jun 26, 2018
From: HEIDARAN, MOHAMMAD A.
To: ANTHROGENESIS CORPORATION
Reel/Frame 046203/0094 →
Assignment of Assignor's Interest Jun 26, 2018
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 046203/0130 →
Assignment of Assignor's Interest Oct 30, 2025
From: CELULARITY INC.
To: CELENIV PTE. LTD.
Reel/Frame 073705/0109 →